ArticleMolecular medicine reports2017

PIM-1 kinase inhibitor SMI-4a exerts antitumor effects in chronic myeloid leukemia cells by enhancing the activity of glycogen synthase kinase 3β.

Rui-Fang Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.